N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide

C19H29N9O5S2 — CID 155117966

IUPACN-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide
SMILESCC(=O)C1=C(SC2CNC(CNS(N)(=O)=O)C2)C(C)[C@H]2[C@@H]([C@@H](C)NC(=O)Cn3cnnn3)C(=O)N12
InChIInChI=1S/C19H29N9O5S2/c1-9-16-15(10(2)24-14(30)7-27-8-22-25-26-27)19(31)28(16)17(11(3)29)18(9)34-13-4-12(21-6-13)5-23-35(20,32)33/h8-10,12-13,15-16,21,23H,4-7H2,1-3H3,(H,24,30)(H2,20,32,33)/t9?,10-,12?,13?,15-,16+/m1/s1
InChIKeyNEBRVIJJEJJMEG-ALCUMJPJSA-N
MW527.63 g/mol
LogP-2.29
Rot. Bonds10

About N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide

N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide (PubChem CID 155117966) has the molecular formula C19H29N9O5S2 and a molecular weight of 527.63 g/mol. Its IUPAC name is N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide.

Molecular Properties

Compound NameN-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide
PubChem CID155117966
Molecular FormulaC19H29N9O5S2
Molecular Weight527.63 g/mol
Exact Mass527.17
IUPAC NameN-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide
SMILESCC(=O)C1=C(SC2CNC(CNS(N)(=O)=O)C2)C(C)[C@H]2[C@@H]([C@@H](C)NC(=O)Cn3cnnn3)C(=O)N12
InChIInChI=1S/C19H29N9O5S2/c1-9-16-15(10(2)24-14(30)7-27-8-22-25-26-27)19(31)28(16)17(11(3)29)18(9)34-13-4-12(21-6-13)5-23-35(20,32)33/h8-10,12-13,15-16,21,23H,4-7H2,1-3H3,(H,24,30)(H2,20,32,33)/t9?,10-,12?,13?,15-,16+/m1/s1
InChIKeyNEBRVIJJEJJMEG-ALCUMJPJSA-N
XLogP-2.29
TPSA194.30 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds10
Heavy Atoms35
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500527.63
LogP ≤ 5-2.29
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Analyze N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide?
The IUPAC name of N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide (CID 155117966) is N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide.
What is the SMILES notation for N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide?
The canonical SMILES for N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide is CC(=O)C1=C(SC2CNC(CNS(N)(=O)=O)C2)C(C)[C@H]2[C@@H]([C@@H](C)NC(=O)Cn3cnnn3)C(=O)N12.
What is the InChIKey of N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide?
The InChIKey is NEBRVIJJEJJMEG-ALCUMJPJSA-N. The full InChI is InChI=1S/C19H29N9O5S2/c1-9-16-15(10(2)24-14(30)7-27-8-22-25-26-27)19(31)28(16)17(11(3)29)18(9)34-13-4-12(21-6-13)5-23-35(20,32)33/h8-10,12-13,15-16,21,23H,4-7H2,1-3H3,(H,24,30)(H2,20,32,33)/t9?,10-,12?,13?,15-,16+/m1/s1.
What are the key properties of N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide?
N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide has a molecular weight of 527.63 g/mol, XLogP of -2.29, 10 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R)-1-[(5R,6R)-2-acetyl-4-methyl-7-oxo-3-[5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-en-6-yl]ethyl]-2-(tetrazol-1-yl)acetamide is sourced from PubChem (CID 155117966), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).